News

Article

ePT--the Electronic Newsletter of Pharmaceutical Technology

EU Issues Study on REACH Implementation

The Society of Chemical Manufacturers and Affiliates (SOCMA) reported in late July that Eurostat, the Statistical Office of the European Communities, recently published a baseline study or the first snapshot of REACH policy in the preregistration phase.

The Society of Chemical Manufacturers and Affiliates (SOCMA) reported in late July that Eurostat, the Statistical Office of the European Communities, recently published a baseline study or the first snapshot of REACH policy in the preregistration phase. SOCMA is the US-based trade association representing custom and batch manufacturers, including contract manufacturers of pharmaceutical intermediates and active pharmaceutical ingredients.

REACH is the European Union (EU) regulation governing the registration, evaluation, authorization, and restriction of chemicals. The regulation was put into place to require registration of approximately 30,000 substances produced or imported within the EU. Substance registration is prioritized according to the phase-in timeline based on the volume and hazardous characteristics of the materials.

The Eurostat study, The REACH Baseline Study: A Tool to Monitor the New EU Policy on Chemicals-REACH, lays out a foundation for future studies using a set of indicators, in order to monitor the success of REACH, according to a SOCMA press release. The three main indicators most closely related to the main objectives of REACH were noted as administrative indicators, a risk and quality indicator system, and supplementary indicators.

The study will monitor changes to risk and the current information base on chemicals, including the quality of such information. The study noted the difficulty in tracking risk reduction and used a subset of chemicals taken out of the approximately 30,000 chemicals regulated under REACH.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content